Company news
Si-bone, Inc. (NASDAQ:SIBN) news
Si-bone, Inc. news releases on 6ix. Latest, Sep 28, 2026: SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone…
Press releases & updates
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
September 28, 2026
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026
August 31, 2026
SI BONE : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
August 4, 2026
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
August 3, 2026
SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026
July 20, 2026
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
June 3, 2026
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
May 11, 2026
SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026
April 30, 2026
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
April 20, 2026
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
February 23, 2026
SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026
February 17, 2026
SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026
February 2, 2026
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
January 11, 2026
Galvanize Therapeutics Appoints Laura Francis to its Board of Directors
November 24, 2025
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025
November 17, 2025
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance
November 9, 2025
SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025
October 19, 2025
SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025
August 25, 2025
Synergy Spine Solutions Appoints Troy Wahlenmaier as Chief Commercial Officer
August 14, 2025
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance
August 3, 2025
SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025
July 28, 2025
SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025
July 13, 2025
SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025
June 4, 2025
SI-BONE to Truist Securities MedTech Conference on June 17, 2025
June 3, 2025
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025
May 27, 2025
SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025
May 5, 2025
SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance
May 4, 2025
SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025
April 13, 2025
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance
February 23, 2025
Bruker Appoints Laura Francis to its Board of Directors
February 20, 2025
SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025
February 2, 2025
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024
January 12, 2025
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
November 19, 2024
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance
November 11, 2024
SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™
November 4, 2024
SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024
October 21, 2024
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
October 9, 2024
SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024
August 21, 2024
SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System
August 19, 2024
SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024
August 5, 2024
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024
August 4, 2024
SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024
July 14, 2024
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
June 4, 2024
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
May 6, 2024
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
May 5, 2024
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
April 28, 2024
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
April 14, 2024
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
March 3, 2024
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
February 25, 2024
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
February 4, 2024